Aspen Pharmacare Holdings Receivables

Aspen Pharmacare Holdings (APNHY) currently reports a receivables of $500M as of June 2026. That compares with $13B in the prior-year period — down 96.3% year over year. Use the charts on this page to explore Aspen Pharmacare Holdings's receivables history and peer comparisons.

Aspen Pharmacare Holdings's receivables decreased from $13B to $500M — a 96.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspen Pharmacare Holdings reported $500M in receivables as of June 2026. That compares with $13B in the prior-year period — down 96.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $500M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aspen Pharmacare Holdings, and consider following APNHY for alerts when major investors trade the stock.

Aspen Pharmacare Holdings is classified in the Healthcare sector. On receivables, it currently shows $500M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APNHY with unrelated industries.